文献速递慢性肾脏病肾移植水电解质与酸碱

无肾患者肾移植前后维生素D代谢物变化

Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric.
PubMed 文献 · Am J Kidney Dis · 2024-05-23

本研究为病例系列,纳入既往双侧肾切除的无肾成人患者,移植时38例、移植后1年25例,用串联质谱测定维生素D代谢物。移植时所有患者均可检出1α,25(OH)2D,提示肾外生成;移植后1年1α,25(OH)2D恢复(+205%),CYP27B1活性增加(+352%),24,25(OH)2D和CYP24A1活性增加3-5倍。

要点

  • 无肾患者仍可检出1α,25(OH)2D,提示存在肾外CYP27B1活性。
  • 移植时25(OH)D与1α,25(OH)2D线性相关(r=0.58, P<0.001),25(OH)D解释34%变异。
  • 肾移植后1年1α,25(OH)2D恢复(+205%),CYP27B1活性增加(+352%)。

核心结论

  • 无肾患者存在低正常水平的1α,25(OH)2D,提示肾脏外可生成活性维生素D。
  • 肾外CYP27B1活性可能更多由底物驱动而非激素调节。
  • 肾移植似可恢复肾脏CYP27B1和CYP24A1活性,使维生素D生成与分解代谢均增加。

研究设计与样本

  • 病例系列研究。
  • 纳入既往双侧肾切除(无肾)且未接受活性维生素D治疗的成人患者。
  • 移植时评估38例,移植后1年评估25例。
  • 采用色谱串联质谱法测定维生素D代谢物。
  • CYP24A1活性以24,25(OH)2D/25(OH)D比值表示,CYP27B1活性以1α,25(OH)2D/25(OH)D比值表示。

主要发现

  • 移植时所有患者均可检出1α,25(OH)2D(4-36pg/mL)。
  • 移植时25(OH)D与1α,25(OH)2D呈线性关系(r=0.58, P<0.001),25(OH)D解释34%的1α,25(OH)2D变异。
  • 移植时1α,25(OH)2D与生物完整PTH或FGF-23无关联。
  • 移植后1年1α,25(OH)2D水平恢复(+205%),CYP27B1活性增加(+352%)。
  • 移植后1年24,25(OH)2D和CYP24A1活性增加3-5倍;1α,25(OH)2D与PTH正相关(ρ=0.603, P=0.04),与25(OH)D或FGF-23无关联。

临床怎么用

  • 无肾患者仍可检出活性维生素D,提示肾外生成,临床评估维生素D状态时需考虑。
  • 肾移植后可恢复维生素D生成与分解代谢,可能影响肾衰竭和移植患者的维生素D补充策略。

局限性

  • 回顾性、观察性研究设计。
  • 队列样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Kidneys are vital for vitamin D metabolism, and disruptions in both production and catabolism occur in chronic kidney disease. Although vitamin D activation occurs in numerous tissues, the kidneys are the most relevant source of circulating active vitamin D. This study investigates extrarenal vitamin D activation and the impact of kidney transplantation on vitamin D metabolism in patients who are anephric. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: Adult patients with previous bilateral nephrectomy (anephric) not receiving active vitamin D therapy evaluated at the time of (N=38) and 1 year after (n=25) kidney transplantation. ANALYTICAL APPROACH: Chromatography with tandem mass spectrometry was used to measure vitamin D metabolites. Activity of CYP24A1 [24,25(OH)2D/25(OH)D] and CYP27B1 [1α,25(OH)2D/25(OH)D] is expressed as metabolic ratios. Differences between time points were evaluated by paired t-test or Wilcoxon matched-pairs signed-rank test. RESULTS: At time of transplantation, 1α,25(OH)2D was detectable in all patients (4-36pg/mL). There was a linear relationship between 25(OH)D and 1α,25(OH)2D levels (r=0.58, P<0.001), with 25(OH)D explaining 34% of the variation in 1α,25(OH)2D levels. There were no associations between 1α,25(OH)2D and biointact parathyroid hormone (PTH) or fibroblast growth factor 23 (FGF-23). One year after transplantation, 1α,25(OH)2D levels recovered (+205%), and CYP27B1 activity increased (+352%). Measures of vitamin D catabolism, 24,25(OH)2D and CYP24A1 activity increased 3- to 5-fold. Also, at 12 months after transplantation, 1α,25(OH)2D was positively correlated with PTH (ρ=0.603, P=0.04) but not with levels of 25(OH)D or FGF-23. LIMITATIONS: Retrospective, observational study design with a small cohort size. CONCLUSIONS: Low-normal levels of 1α,25(OH)2D was demonstrated in anephric patients, indicating production outside the kidneys. This extrarenal CYP27B1 activity may be more substrate driven than hormonally regulated. Kidney transplantation seems to restore kidney CYP27B1 and CYP24A1 activity, as evaluated by vitamin D metabolic ratios, resulting in both increased vitamin D production and catabolism. These findings may have implications for vitamin D supplementation strategies in the setting of kidney failure and transplantation. PLAIN-LANGUAGE SUMMARY: Vitamin D activation occurs in multiple tissues, but the kidneys are considered the only relevant source of circulating levels. This study investigates vitamin D activation outside the kidneys by measuring vitamin D metabolites in 38 patients without kidneys. Active vitamin D was detectable in all patients, indicating production outside of the kidneys. There was a strong relationship between active and precursor vitamin D levels, but no association with mineral metabolism hormones, indicating that vitamin D production was more substrate dependent than hormonally regulated. One year after kidney transplantation, active vitamin D levels increased 2-fold and breakdown products increased 3-fold, indicating that production and degradation of the hormone recovers after kidney transplantation. These findings are relevant for future research into vitamin D supplementation in kidney failure.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Jørgensen HS, de Loor H, Billen J, et al. Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric. Am J Kidney Dis. 2024. PMID: 38796137. doi:10.1053/j.ajkd.2024.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。